Cardlytics, Inc. Common Stock (CDLX) is a publicly traded Communication Services sector company. As of May 21, 2026, CDLX trades at $0.73 with a market cap of $34.89M and a P/E ratio of 0.00. CDLX moved +23.84% today. Year to date, CDLX is -41.52%; over the trailing twelve months it is -63.56%. Its 52-week range spans $0.57 to $5.25. Analyst consensus is neutral with an average price target of $1.25. Rallies surfaces CDLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cardlytics Sees 24.2% Q4 Revenue Drop, UK Sales Jump 35%: Cardlytics achieved self-sustainability in 2025 with full-year billings of $385 million, down 13.3% year over year, while cutting infrastructure costs 40% via faster feature delivery. Q4 2025 revenue fell 24.2% to $56.1 million as US billings ex-Bridge slid 33.5%, while UK sales climbed 35% YoY despite Bank of America exit.
| Metric | Value |
|---|---|
| Price | $0.73 |
| Market Cap | $34.89M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.25% |
| 52-Week High | $5.25 |
| 52-Week Low | $0.57 |
| Volume | 15.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $205.69M |
| Net Income | $-94.69M |
| Gross Margin | 0.00% |
4 analysts cover CDLX: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.25.